Valproate use in women aged 15–44 years: an observational study in general practice

BACKGROUND: Valproate is a known teratogen. In April 2018, the Medicines and Healthcare products Regulatory Agency (MHRA) restricted its use in women and banned use in pregnancy, except for epilepsy with no other effective treatment. To date, there is limited information on valproate prescribing wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Beardsley, Samantha J, Dostal, Isabel, Cole, James, Gutierrez, Ana, Robson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170604/
https://www.ncbi.nlm.nih.gov/pubmed/33619016
http://dx.doi.org/10.3399/BJGPO.2020.0104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170604/
https://www.ncbi.nlm.nih.gov/pubmed/33619016
http://dx.doi.org/10.3399/BJGPO.2020.0104

Ejemplares similares